Tianjin Lisheng Pharmaceutical Co., Ltd. is a leading entity in the pharmaceutical sector, primarily engaged in the research, development, production, and sale of a wide range of pharmaceutical products. The company is dedicated to producing both prescription and over-the-counter medications, with a strong emphasis on cardiovascular, anti-infection, and respiratory drugs. Additionally, it invests in the innovation of traditional Chinese medicine, seeking to integrate modern biopharmaceutical techniques with centuries-old practices. Tianjin Lisheng Pharmaceutical plays a vital role in China's healthcare landscape by catering to hospitals, pharmacies, and healthcare providers across the nation. It is renowned for its commitment to quality, rigorous safety standards, and adherence to international pharmaceutical guidelines. Through strategic partnerships and continual investment in research and development, the company contributes significantly to the availability of effective medical treatments, helping to meet the increasing demands of global healthcare challenges.
Markedsdata leveret af TwelveData og Morningstar